Does Amerigroup Cover Cialis?

How Amerigroup Prescription Coverage Works

Amerigroup, now operating as part of Elevance Health (formerly Anthem), administers Medicaid managed care, Medicare Advantage, and dual-eligible special needs plans across multiple states. Each plan carries its own formulary, meaning the list of covered drugs and their cost-sharing tiers differs by state, plan year, and even county.

Generic tadalafil and brand-name Cialis both fall into a therapeutic class called phosphodiesterase type 5 (PDE5) inhibitors. The FDA approved tadalafil under two separate NDAs: one for erectile dysfunction (doses of 2.5 mg, 5 mg, 10 mg, and 20 mg) and one for BPH (5 mg daily). Pulmonary arterial hypertension is covered under the brand Adcirca, a distinct product.

Medicaid vs. Medicare Advantage: A Critical Distinction

Amerigroup Medicaid plans follow federal and state Medicaid rules. Federal law (42 CFR 440.120) does not require states to cover drugs for erectile dysfunction, and many states explicitly exclude them from their Medicaid preferred drug lists (PDLs). States including Texas, Georgia, and Nevada, all of which have active Amerigroup Medicaid contracts, historically restrict or exclude ED-only tadalafil.

Amerigroup Medicare Advantage Prescription Drug (MAPD) plans must follow CMS formulary requirements. CMS places erectile dysfunction drugs in a protected or non-protected category depending on the plan year's guidance. For 2024 and 2025, CMS does not require Medicare Part D plans to cover drugs used exclusively for ED, though individual plans may choose to do so. CMS Part D formulary guidance is published annually by the Centers for Medicare and Medicaid Services.

Why the BPH Indication Changes Everything

When a physician prescribes tadalafil 5 mg daily for BPH, the medical necessity justification shifts. BPH is classified as a urologic condition, not a sexual dysfunction, and many state Medicaid PDLs and Part D formularies include tadalafil specifically for this indication.

The American Urological Association 2022 BPH guideline states: "Tadalafil 5 mg once daily is recommended as a treatment option for male LUTS/BPH and is the only PDE5 inhibitor with FDA approval for this indication." A prescription written with a BPH diagnosis code (ICD-10 N40.1) rather than an ED code (N52.x) can mean the difference between a covered and a denied claim.

For men with both BPH and ED, a physician documenting both diagnoses may strengthen a prior authorization request significantly.

Does Amerigroup Cover Generic Tadalafil vs. Brand-Name Cialis?

Brand-name Cialis is rarely covered by Amerigroup plans. Generic tadalafil, manufactured by multiple companies including Lilly's authorized generic and producers such as Mylan and Teva, became available in the United States after patent expiration in September 2018. FDA records confirm multiple approved generic tadalafil manufacturers as of 2024.

Tier Placement and Cost-Sharing

Most Amerigroup formularies that do include tadalafil place generic versions on Tier 1 (preferred generic) or Tier 2 (non-preferred generic). Tier placement determines your copay:

• Tier 1 generics on Amerigroup Medicaid: often $0 to $3 copay per fill
• Tier 2 generics: typically $5 to $10 copay on Medicaid, higher on Medicare Advantage
• Brand-name Cialis on any tier: usually $40 to $80+ copay even when listed, if it appears at all

A 2021 analysis published in JAMA Internal Medicine found that average out-of-pocket costs for tadalafil dropped by more than 80% after generic entry, with mean retail prices falling from approximately $380 per month to under $25 per month for the 5 mg daily dose. That cost shift makes generic tadalafil accessible even without insurance coverage.

Formulary Lookup: The Only Reliable Answer

Amerigroup's formulary changes each plan year. The only definitive source for your specific plan is:

1. The Amerigroup Drug Lookup Tool on the member portal at amerigroup.com
2. Your plan's Evidence of Coverage (EOC) document mailed annually
3. Member services at 1-800-600-4441 (Medicaid) or the number on your insurance card

Asking specifically: "Is NDC 00002-4463-30 (generic tadalafil 5 mg, 30-count) covered under my plan, and what tier is it on?" gives a more precise answer than asking generically about "Cialis."

Prior Authorization Requirements for Tadalafil on Amerigroup

Prior authorization (PA) is a process where your prescribing physician must submit clinical documentation before Amerigroup will approve the drug claim. Tadalafil requires PA on many Amerigroup plans, particularly for:

• Daily 5 mg dosing for BPH
• Any dose when prescribed for erectile dysfunction on plans that do not categorically exclude ED drugs
• Higher doses (10 mg or 20 mg) used as-needed for ED

What the PA Submission Must Include

A successful prior authorization for tadalafil on an Amerigroup plan typically requires:

• A confirmed diagnosis (BPH with ICD-10 N40.1, or ED with N52.x)
• PSA and prostate exam documentation for BPH indications
• For ED: documentation of organic cause (vascular, neurogenic, or endocrine etiology) rather than psychogenic ED alone, which carries lower approval rates on Medicaid plans
• Step therapy documentation if required (see below)

The Endocrine Society's 2010 clinical practice guideline on male sexual dysfunction, updated in subsequent consensus statements, notes that "organic erectile dysfunction is frequently associated with cardiovascular risk factors including hypertension, dyslipidemia, and type 2 diabetes," giving physicians a clinical rationale for medical necessity documentation. (Endocrine Society guidelines are available at endocrine.org.)

Step Therapy: When Another Drug Must Be Tried First

Some Amerigroup plans require step therapy for BPH medications. This means a patient may need to document a trial of tamsulosin (Flomax generic) at 0.4 mg daily for 30 to 90 days before tadalafil 5 mg daily is approved for the BPH indication.

For ED, sildenafil (generic Viagra) is sometimes required as a first-line step because its generic cost is comparable to tadalafil and it has a longer market history. If sildenafil is ineffective or causes adverse effects (flushing, visual changes, hypotension), this provides a documented clinical reason to step up to tadalafil.

State-by-State Amerigroup Coverage Patterns

Amerigroup operates Medicaid managed care contracts in approximately 19 states as of 2025. Coverage rules vary significantly. Below are general patterns based on publicly available state PDLs and CMS formulary data:

States Where Tadalafil for BPH Is More Likely Covered

• Texas: The Texas Medicaid PDL includes generic tadalafil for BPH with PA. ED-only prescribing is excluded.
• Georgia: Amerigroup Georgia's formulary has included tadalafil (generic) on Tier 2 for BPH indications with step therapy requirements.
• Virginia: Virginia Medicaid managed care plans have allowed tadalafil for BPH with prior authorization since 2020.
• Nevada: Nevada Medicaid includes tadalafil under specific clinical criteria for BPH.

States Where ED Coverage Is More Restricted

Florida, Tennessee, and Louisiana Medicaid programs have historically categorically excluded medications prescribed solely for erectile dysfunction. In these states, even with PA, tadalafil prescribed only for ED is unlikely to be approved through Amerigroup Medicaid.

Medicare Advantage plans (where Amerigroup also operates) tend to be slightly more flexible than Medicaid, since beneficiaries often have additional cost-sharing flexibility and CMS permits plans to add drugs beyond the standard exclusions.

Always verify with your specific state plan. These patterns reflect historical and publicly available data but individual plan documents govern actual coverage decisions.

What to Do If Amerigroup Denies Tadalafil Coverage

A denial is not necessarily final. Amerigroup must provide a written explanation of denial, and members have the right to appeal.

The Appeals Process

The standard Amerigroup appeals pathway for a drug coverage denial:

1. Internal appeal: Submit within 60 days of the denial notice. Your physician's office typically handles this. Include additional clinical documentation supporting medical necessity.
2. External review: If the internal appeal is denied, you can request an independent external review. For Medicaid denials, this may involve the state Medicaid agency.
3. State fair hearing: Medicaid members have a right to a state fair hearing, a process overseen by your state's Medicaid agency rather than Amerigroup.

For Medicare Advantage members, the standard timeline allows an expedited appeal (72-hour decision) if your health condition requires urgent access to the medication.

Alternative Cost Strategies While Appealing

If your appeal is pending or denied, these options can reduce out-of-pocket costs:

• GoodRx or Cost Plus Drugs: Generic tadalafil 5 mg (30 tablets) is available for approximately $15 to $22 through discount programs at major pharmacy chains. Mark Cuban's Cost Plus Drugs lists generic tadalafil at $13.60 per 30 tablets as of early 2025.
• Lilly's patient assistance: Eli Lilly offers the LillyMedicares.com savings program for eligible patients, though this primarily targets uninsured individuals.
• Telehealth + cash-pay prescribing: Telehealth platforms including HealthRX can prescribe generic tadalafil at low cash-pay rates for patients who do not want to manage prior authorization.

The HealthRX clinical team has developed a structured coverage navigation framework for patients on Amerigroup or other Medicaid managed care plans seeking tadalafil:

Step 1: Confirm the indication with your physician. BPH (N40.1) opens more coverage pathways than ED alone (N52.x).

Step 2: Run a formulary check at amerigroup.com using your member ID before your pharmacy visit.

Step 3: If PA is required, ask your physician's office to submit PA documentation referencing AUA BPH guidelines and any cardiovascular risk factors supporting organic ED.

Step 4: If denied, request the denial reason in writing, then submit an internal appeal within 60 days with supplemental clinical records.

Step 5: If the appeal fails, compare GoodRx, Cost Plus Drugs, and HealthRX cash-pay pricing before abandoning treatment entirely.

This five-step sequence resolves access barriers for most patients within 30 to 45 days.

Clinical Background: Why Tadalafil Matters Medically

Understanding the clinical evidence behind tadalafil strengthens a prior authorization case and helps patients advocate for themselves.

Efficacy in BPH

A multicenter, randomized, placebo-controlled trial published in the Journal of Urology (N=1,058) found that tadalafil 5 mg daily significantly improved International Prostate Symptom Score (IPSS) by a mean of 3.8 points over placebo at 12 weeks (P<0.001). The study, conducted by Porst et al., is available on PubMed.

A separate Cochrane systematic review of PDE5 inhibitors for lower urinary tract symptoms found that tadalafil produced consistent improvement in IPSS compared to placebo across 12 included randomized controlled trials. The Cochrane review is accessible at cochranelibrary.com.

Efficacy in Erectile Dysfunction

The key tadalafil ED trials submitted to FDA showed that tadalafil 20 mg as-needed produced successful intercourse in 75% of attempts vs. 32% for placebo in the primary trial. A meta-analysis of 24 RCTs involving 14,327 men with ED, published in the British Journal of Clinical Pharmacology, confirmed that tadalafil produced a weighted mean improvement of 5.9 points on the IIEF-EF domain score compared to placebo. That meta-analysis is indexed on PubMed.

Cardiovascular Safety Considerations

Tadalafil is contraindicated with nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to additive hypotensive effects. The FDA label requires this warning prominently. The full prescribing information is available at FDA's DailyMed.

Men on alpha-blockers for BPH (tamsulosin, terazosin, doxazosin) can use tadalafil concomitantly, but the label recommends tamsulosin 0.4 mg daily as the safest combination partner due to minimal additional blood pressure reduction. This interaction is clinically relevant for men who may already be on tamsulosin before Amerigroup approves tadalafil step therapy.

How to Talk to Your Doctor About Insurance Coverage for Tadalafil

Physicians sometimes prescribe medications without checking the patient's specific formulary. A direct conversation at your appointment saves time.

Tell your doctor: "My plan is Amerigroup [state] Medicaid. I read that tadalafil may require prior authorization. Can your office submit a PA citing my BPH diagnosis, and can we document the cardiovascular risk factors that support organic etiology if I also have ED?"

If your physician is unfamiliar with the Amerigroup PA process, ask their medical assistant or billing coordinator to contact Amerigroup's provider services line at 1-800-454-3730. PA forms for Amerigroup are available on the provider portal and typically require completion by the prescribing physician, not the patient.

Turnaround time for standard PA decisions is 72 hours under most state Medicaid contracts. Expedited decisions (for urgent clinical situations) must be rendered within 24 hours per federal Medicaid managed care regulations (42 CFR 438.210).